JSK Biomed
Pioneering the future of anti-aging with innovative needle-free transdermal drug delivery technology.
Pioneering the future of anti-aging with innovative needle-free transdermal drug delivery technology.
JSK Biomed is a pioneering company that focuses on the research and development of bio-medical devices, with a primary focus on anti-aging solutions. Their flagship product, Mirage Jet, is a revolutionary needle-free injector that redefines the transdermal drug delivery landscape. This innovative technology offers a safe and effective solution for anti-aging treatments without the use of needles. Moreover, JSK Biomed is committed to the advancement of bio-equipment and the progression of transdermal drug delivery systems. With its establishment in 2015, the company operates within the Health Care and Medical Devices industries. In June 2020, the company secured a substantial KRW1.20B Series A investment from Kudos Ventures, marking a significant milestone in its development and growth trajectory.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | KRW1.20B | 1 |
|
03 Jun 2020 |
| Non Equity Assistance | Unknown | 1 | TIPS Program | 01 Oct 2019 |
No recent news or press coverage available for JSK Biomed.
We care about your data, and we'd love to use cookies make your experience better.